Researchers from the University of Minnesota Medical School and College of Pharmacy have found that high costs for hepatic encephalopathy treatment in patients with end-stage liver disease were ...

LAVAL, QC / ACCESS Newswire / May 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and its gastroenterology (GI) business, Salix ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Fewer patients treated with rifaximin had an overt ...

Arun B. Jesudian, MD: We’ve mentioned GI [gastrointestinal] bleeding, we’ve mentioned hypovolemia, dehydration. Elliot, before you alluded to infections [as] a problem in this population. How do those ...

LONDON--(BUSINESS WIRE)--The global encephalopathy treatment market 2019-2023 is expected to post a CAGR of close to 5% during the forecast period, according to the latest market research report by ...

Ocera has received Fast Track Designation and Orphan Drug Status and plans to initiate Phase 2 studies with OCR-002 in 2011. SAN DIEGO, Dec. 15, 2010 /PRNewswire/ -- Ocera Therapeutics, Inc. announced ...

This study shows that the incidence of hepatic encephalopathy was lower in cirrhotic patients with upper gastrointestinal bleed treated with lactulose as compared with patients not treated with ...

Please provide your email address to receive an email when new articles are posted on . Artificial neural networks model better predicted 28-day mortality in hepatic encephalopathy vs. MELD, MELD-Na ...

The descent into dementia can feel like traversing a minefield, coming across new symptoms without the hope of a cure. But some dementia patients, even up to 10% of people diagnosed with the condition ...

The "Global Encephalopathy Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The Global Encephalopathy Treatment Market is anticipated to grow at a CAGR of 4.75% ...